Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Innovation
Share your love
Azura Ophthalmics: Phase 2 Results for AZR-MD-001
Azura Ophthalmics reported positive top-line efficacy and safety outcomes from a phase 2 investigation of AZR-MD-001 in individuals experiencing Contact Lens Discomfort (CLD) due to challenges in comfortably wearing lenses and demonstrating signs of meibomian gland dysfunction (MGD). The trial…
Ocutrx Unveils OcuLenz AR/XR Headset for Advanced AMD
Ocutrx Technologies has launched the OcuLenz AR/XR headset, a cutting-edge device specifically engineered to elevate visual clarity and redefine the possibilities for those with advanced age-related macular degeneration. The OcuLenz AR/XR headset distinguishes itself with its lightweight and user-friendly design.…
Blind Canvas Project by Ora and BlindCAN Film Festival
Ora and the BlindCAN Film Festival have jointly unveiled The Blind Canvas Project, an initiative that leverages the capabilities of storytelling and generative artificial intelligence (AI) to cultivate a more profound comprehension of the lives and narratives of individuals affected…
Japan’s PMDA Approves Aurion Biotech’s NDA
Aurion Biotech announced that it has received regulatory approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) for its pioneering cell therapy, VyznovaTM, designed for treating bullous keratopathy of the cornea. According to the company, this represents the world’s first…
VSY’s SVT Technology Secures Patent Grant in the US
Andreas C. Kühnel, Managing Director at VSY Biotechnology announced that the company’s innovative Sinusoidal Vision Technology (SVT®) has received its U.S. patent from the United States Patent and Trademark Office. This significant milestone is a testament to the company’s commitment…
Tiny Eye Implant: A Diabetes Treatment Option
In Sweden, researchers have created a microscale device designed for implantation in the eye, opening up new paths for cell-based treatments for conditions like diabetes. Developed by a team from KTH Royal Institute of Technology and Karolinska Institutet, this 3D-printed…
XPANCEO Raises $40M for AR Vision Contact Lenses
XPANCEO, a deep tech startup, has secured $40 million in seed funding to introduce groundbreaking contact lenses with augmented reality (AR) vision features. These funds will be strategically channeled into the development of the next prototype, consolidating multiple features within…
ICTER’s New Imaging Method for Early Diagnosis
Optical coherence tomography (OCT) stands as one of the most foundational and accurate tests for diagnosing eye diseases. While it excels in a detailed examination of individual eye structures, its effectiveness diminishes when applied to the early detection of subtle…
VSY Biotechnology AcrivaUD Trinova Pro C Pupil Adaptive® I OBN
VSY Biotechnology GmbH, an innovation-driven company with progressive R&D activities in ophthalmology, is readying to share the first clinical experiences of AcrivaUD Trinova Pro C Pupil Adaptive®, the first and only trifocal IOL that combines patented enhanced Sinusoidal Vision Technology…
What Is Bitemporal Hemianopia? | OBN
Bitemporal hemianopia, also known as bitemporal heteronymous hemianopia, is a visual field defect that affects both eyes, resulting in the loss of vision in the outer (temporal) halves of the visual field. In simpler terms, individuals with bitemporal hemianopia experience…